Shots:

• Daiichi Sankyo signs an outsourcing Agreement to Manufacture AstraZeneca COVID-19 Vaccine AZD1222 in Japan
• Following the AstraZeneca’s agreement with the Japanese government to manufacture and supply COVID-19 vaccine- Daiichi Sankyo will use undiluted solutions to manufacture COVID-19 vaccines in the Japan including vial filling and packaging
• Additionally- Daiichi Sankyo will continue to work to advance ongoing research and development of a Nafamostat inhalation formulation (DS2319) as well as an mRNA vaccine (DS-5670) and also ensures the supply of the AstraZeneca COVID-19 vaccine in Japan

 ­ Ref: Daichii Sankyo | Image: Daichii Sankyo